cheshtasharma

About Cheshta Sharma

This author has not yet filled in any details.
So far Cheshta Sharma has created 1323 blog entries.

GOP Tech Plans Aims at H1-B Visas, Taxes, and Patent Law

Senator Orrin Hatch unveiled an ambitious agenda to boost the US tech industry which included proposed reforms to contentious issues like immigration and corporate tax policy. In a speech announcing an “innovation agenda” for the new congress, the senator also touted his ties with the president trump and said he would act as a [...]

By |2017-09-08T10:40:21+05:30March 30th, 2017|International, Patent|0 Comments

Regeneron, Sanofi-Aventis sue for declaration that dermatitis treatment Dupixent doesn’t infringe Amgen patent

On Monday, March 20th, American pharmaceutical companies Sanofi-Aventis US, a subsidiary of France-based Sanofi S.A. (NYSE:SNY), and Regeneron (NASDAQ:REGN) were listed as plaintiffs in a suit filed to seek declaratory judgment of non-infringement of a patent held by American biopharma firm Amgen (NASDAQ:AMGN). Sanofi-Aventis and Regeneron are hoping to protect their market interest in a treatment developed to help patients [...]

By |2017-09-08T10:41:28+05:30March 30th, 2017|International, Patent|0 Comments

Recognizing the death of software patents: is OIN to blame?

Since it is already happening on the face of it and LG adopts similar tactics that prevent responsibility or reaction by proxyfing to trolls. This is the kind of things OIN was supposed to protect but we have seen hardly any evidence that OIN is taking any effective measures to protect against them. "With [...]

By |2017-09-08T10:42:42+05:30March 30th, 2017|Patent|0 Comments
Go to Top